Anu Mahadevan

CEO at Organix

Anu Mahadevan has a Ph.D., Organic Chemistry, 1994 Purdue University Research under Professor Phillip L. Fuchs. She is a Chairwoman at Danmir Therapeutics and Consulting partner at Blue Therapeutics and Member of the Drug Discovery for the Nervous System Study Section.

Links

Timeline

  • CEO

    Current role